Your browser doesn't support javascript.
loading
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas.
Díaz, Luis Antonio; Fuentes-López, Eduardo; Ayares, Gustavo; Idalsoaga, Francisco; Arnold, Jorge; Márquez-Lomas, Andrea; Ramírez, Carolina A; Medel, María Paz; Viñuela, Francisca; Lacalle, Lucas; Roblero, Juan Pablo; Ferreccio, Catterina; Lazo, Mariana; Brahmania, Mayur; Singal, Ashwani K; Dirchwolf, Melisa; Méndez-Sánchez, Nahum; Chavez-Tapia, Norberto; Guerra, Patricia; Restrepo, Juan Carlos; Oliveira, Claudia P; Lombardo, Julissa; Sánchez, Abel; Elizondo, Martín; Tagle, Martín; Padilla, Martín; Sánchez, Marco; Carrera, Enrique; Girala, Marcos; Chery, Omega; Castellanos-Fernández, Marlen; Barrera, Francisco; Lazarus, Jeffrey V; Kamath, Patrick S; Bataller, Ramon; Arrese, Marco; Arab, Juan Pablo.
Afiliación
  • Díaz LA; Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Fuentes-López E; Departamento de Ciencias de la Salud, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Ayares G; Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Idalsoaga F; Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Arnold J; Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Márquez-Lomas A; Escuela de Medicina, Universidad Anáhuac Mayab, Mérida, México.
  • Ramírez CA; Departamento de Anestesiología, Clínica Las Condes, Santiago, Chile.
  • Medel MP; Departamento de Medicina Familiar, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Viñuela F; Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Lacalle L; Departamento de Ciencias de la Salud, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Roblero JP; Sección Gastroenterología, Hospital Clínico Universidad de Chile, Escuela de Medicina Universidad de Chile, Santiago, Chile.
  • Ferreccio C; Public Health Department, Pontificia Universidad Católica de Chile, Santiago, Chile; Advanced Center for Chronic Diseases, ACCDis, Santiago, Chile.
  • Lazo M; Department of Community Health and Prevention and Urban Health Collaborative, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA; Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Brahmania M; Department of Medicine, Division of Gastroenterology, Western University, London Health Sciences Center, London, ON, Canada.
  • Singal AK; Department of Medicine, University of South Dakota Sanford School of Medicine, Division of Transplant Hepatology, Avera Transplant Institute, Sioux Falls, SD, USA.
  • Dirchwolf M; Unidad de Trasplante Hepático, Servicio de Hepatología, Hospital Privado de Rosario, Rosario, Argentina.
  • Méndez-Sánchez N; Liver Research Unit, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Chavez-Tapia N; Medica Sur Clinic & Foundation, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Guerra P; Instituto de Gastroenterología Boliviano-Japonés, Cochabamba, Bolivia.
  • Restrepo JC; Unidad de Hepatología del Hospital Pablo Tobon Uribe, Grupo de Gastrohepatología de la Universidad de Antioquia, Medellín, Colombia.
  • Oliveira CP; Division of Clinical Gastroenterology and Hepatology, Hospital das Clínicas HCFMUSP, Department of Gastroenterology, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil.
  • Lombardo J; Hospital Punta Pacífica, Ciudad de Panamá, Panamá.
  • Sánchez A; Gastroenterología Endoscopia Digestiva Hepatología, Hospital Roosevelt, Ciudad de Guatemala, Guatemala.
  • Elizondo M; Hepatic Biliary and Pancreatic National Center-Teaching and Assistance Unit (UDA) and Bi-lnstitutional Unit of Liver Transplantation-Military Hospital, Montevideo, Uruguay.
  • Tagle M; Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Padilla M; Universidad Nacional Mayor de San Marcos, Hospital Nacional Guillermo Almenara, Lima, Peru.
  • Sánchez M; Hospital Escuela, Tegucigalpa, Honduras.
  • Carrera E; Hospital Eugenio Espejo, Quito, Ecuador.
  • Girala M; Hospital de Clínicas, Universidad Nacional de Asunción, Asunción, Paraguay.
  • Chery O; Ministry of Public Health, Haiti.
  • Castellanos-Fernández M; Department of Research and Teaching, Institute of Gastroenterology, University of Medical Sciences of Havana, Havana City, Cuba.
  • Barrera F; Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Kamath PS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Bataller R; Center for Liver Diseases, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, PA, USA.
  • Arrese M; Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Envejecimiento y Regeneración (CARE), Facultad de Ciencias Biológicas, Mérida, México.
  • Arab JP; Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: jparab@uc.cl.
Lancet Gastroenterol Hepatol ; 7(6): 552-559, 2022 06.
Article en En | MEDLINE | ID: mdl-35430032
ABSTRACT
Non-alcoholic fatty liver disease (NAFLD) affects 20-25% of the general population and is associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD risk factors are modifiable and, therefore, potentially amenable to being reduced by public health policies. To date, there is no information about NAFLD-related public health policies in the Americas. In this study, we analysed data from 17 American countries and found that none have established national public health policies to decrease NAFLD-related burden. There is notable heterogeneity in the existence of public health policies to prevent NAFLD-related conditions. The most common public health policies were related to diabetes (15 [88%] countries), hypertension (14 [82%] countries), cardiovascular diseases (14 [82%] countries), obesity (nine [53%] countries), and dyslipidaemia (six [35%] of countries). Only seven (41%) countries had a registry of the burden of NAFLD, and efforts to raise awareness in the Americas were scarce. The implementation of public health policies are urgently needed in the Americas to decrease the burden of NAFLD.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Chile

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Chile